by Eric Christianson | Jun 18, 2023 | Neurology, Pain, and Musculoskeletal Medication and Disease State Clinical Pearls
NSAIDs are a commonly used class of analgesic medication. There are numerous factors that may determine which one we choose. We’ll lay out some of the most important differences between these agents and summarize this information in our NSAID comparison table at...
by Eric Christianson | Jun 14, 2023 | Infectious Disease and Oncology Medication and Disease State Clinical Pearls
It is that time of the year with creepy/crawly ticks running rampant. This presents an excellent opportunity to go over some of my Lyme disease clinical practice pearls! You never know when these might show up on a board exam! Lyme Disease Clinical Practice Pearls...
by Eric Christianson | Jun 7, 2023 | Clinical Pharmacy News and New Drug Updates
A new SGLT2i is now on the market, promoting a new option for diabetes management. Bexagliflozin (Brenzavvy) got FDA approval in January of this year adding it to the list of SGLT2 inhibitors. With a few already on the scene, it bears the question, is bexagliflozin...
by Eric Christianson | Jun 4, 2023 | Clinical Pharmacy News and New Drug Updates
Earlier this month the FDA approved Rexulti (Brexpiprazole) for the treatment of agitation in patients with dementia due to Alzheimer’s. Originally approved as an atypical antipsychotic used for schizophrenia, or an adjunct therapy for major depressive disorder,...
by Eric Christianson | May 31, 2023 | Psychiatry and Addiction Medication and Disease State Clinical Pearls
Buspirone is an anti-anxiety medication that can be used for chronic management. I’ll outline some of the most important clinical pearls and share some anecdotal education in this blog post. The Good – Buspirone Clinical Pearls Buspirone is well tolerated...
